天潤雲(02167.HK)盈喜:預計中期轉虧為盈
格隆匯8月14日丨天潤雲(02167.HK)公吿,公司預計截至2024年6月30日止六個月(i)於報吿期錄得收入約人民幣236百萬元,較截至2023年6月30日止六個月的約人民幣212.9百萬元增長約10%;及(ii)於報吿期錄得純利超過人民幣10百萬元,而截至2023年6月30日止六個月則錄得虧損淨額約人民幣2.0百萬元。
董事會認為,預期轉虧為盈主要歸因於:1.SaaS解決方案的收入增加,乃由於公司的AI產品供應不斷提升,並改善其特性及能力以吸引新客户;及2.公司研發流程的有效優化及提高其效率及產能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.